The activity of dihydropyrimidine dehydrogenase in human blood cells.
Van Kuilenburg
A B
AB
Department Clinical Chemistry, Academic Medical Center, University of Amsterdam, The Netherlands.
Van Lenthe
H
H
Blom
M J
MJ
Mul
E P
EP
Van Gennip
A H
AH
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001792:Blood Platelets / Q000201:enzymology*; D003131:Combined Modality Therapy; D042943:Dihydrouracil Dehydrogenase (NADP); D004912:Erythrocytes / Q000201:enzymology; D006098:Granulocytes / Q000201:enzymology; D006801:Humans; D007962:Leukocytes / Q000201:enzymology*; D007963:Leukocytes, Mononuclear / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology; D008875:Middle Aged; D009000:Monocytes / Q000201:enzymology; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy / Q000201:enzymology / Q000532:radiotherapy; D010088:Oxidoreductases / Q000097:blood*; D012044:Regression Analysis
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP)